FDA27American Society of Hematology Annual Meeting and Exposition
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 611430 Professional and Management Development Training
- Points of contact
-
- OC Acquisition Liaison oacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring support services for the American Society of Hematology Annual Meeting and Exposition, with an estimated award date of October 1, 2026. The FDA's Oncology Program requires contractor support to deploy subject matter experts to state, local, and international sites to provide expertise in disease intervention, public health practices, research, and regulatory and policy matters related to oncology drug review and development. This annual conference addresses blood diseases and their cancer impacts and is critical to the Oncology Program's mission of external engagement, recruiting, and public awareness.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Office of Acquisitions at oacquisitions@fda.hhs.gov.
Forecast text
FDA Oncology Program sends subject matter experts to state, local and international sitesto provide and share expertise in disease intervention, public health practices, research, regulatory andpolicy related to oncology drug review and development. etc. This is critical for external engagement,recruiting efforts and public awareness. This is an annual conference and the conference deals withBlood Diseases and impacts on Cancer. This is critical to the Oncology Mission.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast